Cyclin E1 and cyclin E2, which interact with cyclin-dependent kinase 2 (Cdk2), are known to stimulate cell cycle progression and initiation of HCC (Sonntag et al., 2018). This evidence concerns the gene CDK2 and hepatocellular carcinoma.